HCAT
Price
$2.21
Change
+$0.03 (+1.38%)
Updated
Feb 4, 02:47 PM (EDT)
Capitalization
154.55M
27 days until earnings call
Intraday BUY SELL Signals
PHR
Price
$12.80
Change
+$0.02 (+0.16%)
Updated
Feb 4, 03:10 PM (EDT)
Capitalization
770.47M
56 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

HCAT vs PHR

Header iconHCAT vs PHR Comparison
Open Charts HCAT vs PHRBanner chart's image
Health Catalyst
Price$2.21
Change+$0.03 (+1.38%)
Volume$100
Capitalization154.55M
Phreesia
Price$12.80
Change+$0.02 (+0.16%)
Volume$12.33K
Capitalization770.47M
HCAT vs PHR Comparison Chart in %
View a ticker or compare two or three
VS
HCAT vs. PHR commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HCAT is a Hold and PHR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (HCAT: $2.18 vs. PHR: $12.78)
Brand notoriety: HCAT and PHR are both not notable
Both companies represent the Services to the Health Industry industry
Current volume relative to the 65-day Moving Average: HCAT: 116% vs. PHR: 219%
Market capitalization -- HCAT: $154.55M vs. PHR: $770.47M
HCAT [@Services to the Health Industry] is valued at $154.55M. PHR’s [@Services to the Health Industry] market capitalization is $770.47M. The market cap for tickers in the [@Services to the Health Industry] industry ranges from $31.36B to $0. The average market capitalization across the [@Services to the Health Industry] industry is $1.51B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HCAT’s FA Score shows that 1 FA rating(s) are green whilePHR’s FA Score has 1 green FA rating(s).

  • HCAT’s FA Score: 1 green, 4 red.
  • PHR’s FA Score: 1 green, 4 red.
According to our system of comparison, HCAT is a better buy in the long-term than PHR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HCAT’s TA Score shows that 3 TA indicator(s) are bullish while PHR’s TA Score has 4 bullish TA indicator(s).

  • HCAT’s TA Score: 3 bullish, 4 bearish.
  • PHR’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, PHR is a better buy in the short-term than HCAT.

Price Growth

HCAT (@Services to the Health Industry) experienced а -1.80% price change this week, while PHR (@Services to the Health Industry) price change was -15.87% for the same time period.

The average weekly price growth across all stocks in the @Services to the Health Industry industry was -4.74%. For the same industry, the average monthly price growth was -8.76%, and the average quarterly price growth was -7.84%.

Reported Earning Dates

HCAT is expected to report earnings on Mar 03, 2026.

PHR is expected to report earnings on Apr 01, 2026.

Industries' Descriptions

@Services to the Health Industry (-4.74% weekly)

This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHR($770M) has a higher market cap than HCAT($155M). HCAT YTD gains are higher at: -8.787 vs. PHR (-24.468). PHR has higher annual earnings (EBITDA): 26.3M vs. HCAT (-32.74M). PHR has more cash in the bank: 106M vs. HCAT (91.5M). PHR has less debt than HCAT: PHR (10.4M) vs HCAT (172M). PHR has higher revenues than HCAT: PHR (463M) vs HCAT (316M).
HCATPHRHCAT / PHR
Capitalization155M770M20%
EBITDA-32.74M26.3M-124%
Gain YTD-8.787-24.46836%
P/E RatioN/AN/A-
Revenue316M463M68%
Total Cash91.5M106M86%
Total Debt172M10.4M1,654%
FUNDAMENTALS RATINGS
HCAT vs PHR: Fundamental Ratings
HCAT
PHR
OUTLOOK RATING
1..100
5752
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
33
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9690
PRICE GROWTH RATING
1..100
6592
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
9090

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HCAT's Valuation (27) in the null industry is in the same range as PHR (33). This means that HCAT’s stock grew similarly to PHR’s over the last 12 months.

HCAT's Profit vs Risk Rating (100) in the null industry is in the same range as PHR (100). This means that HCAT’s stock grew similarly to PHR’s over the last 12 months.

PHR's SMR Rating (90) in the null industry is in the same range as HCAT (96). This means that PHR’s stock grew similarly to HCAT’s over the last 12 months.

HCAT's Price Growth Rating (65) in the null industry is in the same range as PHR (92). This means that HCAT’s stock grew similarly to PHR’s over the last 12 months.

HCAT's P/E Growth Rating (100) in the null industry is in the same range as PHR (100). This means that HCAT’s stock grew similarly to PHR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HCATPHR
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 14 days ago
70%
Bullish Trend 13 days ago
77%
Declines
ODDS (%)
Bearish Trend 6 days ago
84%
Bearish Trend 2 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
HCAT
Daily Signal:
Gain/Loss:
PHR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AIEMX14.490.16
+1.12%
Alger Emerging Markets I
PENNX10.02N/A
N/A
Royce Small-Cap Fund Invmt
CAPSX9.46-0.01
-0.11%
Federated Hermes Capital Income IS
CMPCX18.44-0.05
-0.27%
Calvert Small/Mid-Cap C
TIGRX15.24-0.07
-0.46%
Nuveen Core Equity R6

HCAT and

Correlation & Price change

A.I.dvisor indicates that over the last year, HCAT has been loosely correlated with KVYO. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if HCAT jumps, then KVYO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HCAT
1D Price
Change %
HCAT100%
-5.22%
KVYO - HCAT
47%
Loosely correlated
-10.68%
PHR - HCAT
46%
Loosely correlated
-3.26%
CSGS - HCAT
46%
Loosely correlated
-0.15%
EVCM - HCAT
46%
Loosely correlated
-8.56%
RDVT - HCAT
45%
Loosely correlated
-11.58%
More

PHR and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHR has been loosely correlated with COIN. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if PHR jumps, then COIN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHR
1D Price
Change %
PHR100%
-3.26%
COIN - PHR
57%
Loosely correlated
-4.36%
CLSK - PHR
55%
Loosely correlated
+2.90%
QTWO - PHR
49%
Loosely correlated
-5.70%
QLYS - PHR
49%
Loosely correlated
-5.54%
RIOT - PHR
49%
Loosely correlated
+0.13%
More